Antimicrobial resistance

Antimicrobial resistance  (medical concept)
Interest of	• CARB-X • Global Leaders Group on Antimicrobial Resistance
While it is a genuine problem, by 2024 there were signs it was exaggerated in corporate media campaigns for deep political purposes, in order to push nefarious "treatments".

Antimicrobial resistance Antimicrobial resistance (AMR) occurs when microbes evolve mechanisms that protect them from antibiotics (antimicrobials), which are drugs used to treat infections.

While it is a genuine problem, by 2024 there were signs it was exaggerated in corporate media campaigns for deep political purposes, in order to push nefarious "treatments".

Official narrative

In 2023, the WHO concluded that "Antimicrobial resistance (AMR) is one of the top global public health and development threats. There is an inadequate research and development pipeline in the face of rising levels of resistance, and urgent need for additional measures to ensure equitable access to new and existing vaccines, diagnostics and medicines." Jabs against "just 23 pathogens", including tuberculosis, Klebsiella pneumoniae, norovirus, respiratory syncytial virus and gonorrhea, could reduce the number of antibiotics needed by 22% globally per year".

Coordinated campaign

In October 2024, the World Economic Forum published an analysis claiming that "antimicrobial resistance (AMR) is gaining momentum, contributing to 5 million deaths in 2019 and potentially causing millions more in the coming decades, calling for "collaborating across sectors globally to combat its spread.

In a November 2024 summit in Jeddah, Tedros Ghebreyesus, the Director-General of the WHO warned of an "ongoing antimicrobial crisis", where antimicrobial resistance (AMR) action "is equally as urgent as climate action." The Conference's outcome document, 'The Jeddah Declaration" contains important initiatives such as the formation of a global scientific committee to support antimicrobial resistance, the establishment of a 'biotechnology bridge' to support research and development, in addition to a proposed knowledge centre that aims to raise community awareness on AMR.

Sally Davies, UK’s special envoy for antimicrobial resistance, said in November 2024 that "the rising death toll from drug-resistant bugs is very scary and people do not even realise it is happening..Some people talk about [AMR] being a pandemic – it is. Is it a slow-developing one, an insidious one, or what? I don’t mind the words you want to use, but it’s pretty awful"

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.